BIO-Europe 2026
Panel Clinical Strategy track
China’s Clinical Revolution: From Regional Player to Global Innovation Engine
Tue, Nov 10, 2026 · 9:45–10:45 AM CET Clinical Strategy Stage, Koelnmesse
About this session
Examine what Western partners must resolve on evidence, data access and policy risk before committing to a China-origin asset Understand how to leverage China’s speed, patient access and regulatory flexibility to accelerate global development timelines Explore the surge in licensing agreements between global pharma and Chinese innovators and what makes China attractive for global partnerships Understand the regulatory evolution in the regional and their impact on development
